GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianda Pharmaceuticals Ltd (HKSE:00455) » Definitions » Market Cap

Tianda Pharmaceuticals (HKSE:00455) Market Cap : HK$513.9 Mil (As of Jun. 11, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Tianda Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Tianda Pharmaceuticals's share price for the quarter that ended in Dec. 2023 was HK$0.218. Tianda Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 2,150.0 Mil. Therefore, Tianda Pharmaceuticals's market cap for the quarter that ended in Dec. 2023 was HK$468.7 Mil.

Tianda Pharmaceuticals's quarterly market cap increased from Sep. 2022 (HK$397.8 Mil) to Jun. 2023 (HK$468.7 Mil) but then stayed the same from Jun. 2023 (HK$468.7 Mil) to Dec. 2023 (HK$468.7 Mil).

Tianda Pharmaceuticals's annual market cap increased from Mar. 2021 (HK$434.3 Mil) to Mar. 2022 (HK$501.0 Mil) but then declined from Mar. 2022 (HK$501.0 Mil) to Dec. 2023 (HK$468.7 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Tianda Pharmaceuticals's Enterprise Value for Today is HK$467.2 Mil.


Tianda Pharmaceuticals Market Cap Historical Data

The historical data trend for Tianda Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianda Pharmaceuticals Market Cap Chart

Tianda Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 516.01 344.01 434.31 500.96 468.71

Tianda Pharmaceuticals Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Jun23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 470.86 500.96 397.76 468.71 468.71

Competitive Comparison of Tianda Pharmaceuticals's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Tianda Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianda Pharmaceuticals's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianda Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Tianda Pharmaceuticals's Market Cap falls into.



Tianda Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Tianda Pharmaceuticals's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=HK$0.218*2150.04
=HK$468.7

Tianda Pharmaceuticals's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=HK$0.218*2150.04
=HK$468.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tianda Pharmaceuticals  (HKSE:00455) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Tianda Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Tianda Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianda Pharmaceuticals (HKSE:00455) Business Description

Traded in Other Exchanges
N/A
Address
CITIC Tower, No. 1 Tim Mei Avenue, Suites 2405-2410, 24th Floor, Central, Hong Kong, HKG
Tianda Pharmaceuticals Ltd is engaged in R&D, manufactures and sales of pharmaceutical, biotechnology and healthcare products. The group also engages in R&D of Chinese medicine and manufacture and sales of Chinese medicine products, and the provision of Chinese medical services. Its operating segments include Chinese medicine business; Medical and healthcare services; and Pharmaceuticals and medical technologies business. The company derives majority of the revenue from Pharmaceuticals and medical technologies business.
Executives
Tianda Group Limited 2101 Beneficial owner
Fang Wen Quan 2201 Interest of corporation controlled by you

Tianda Pharmaceuticals (HKSE:00455) Headlines

No Headlines